Literature DB >> 15925050

The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial.

Batool Hossein Rashidi1, Fatemeh Sarvi, Ensieh Shahrokh Tehrani, Farid Zayeri, Mansoureh Movahedin, Navid Khanafshar.   

Abstract

OBJECTIVE: To compare the effect of HMG and rhFSH on oocyte quality in ICSI cycle.
SETTING: Vali-e-Asr university teaching hospital.
METHOD: Prospective single-blind randomized clinical trial.
SUBJECTS: Sixty women undergoing ovarian stimulation for ICSI were randomized to receive a standard protocol of either HMG or rhFSH in down-regulation cycles.
INTERVENTIONS: Prior to microinjection, each oocyte was assessed regarding the nuclear maturity, morphology of zona plucida, cytoplasmic appearance and polar body morphology. Fertilization rate was followed. MAIN OUTCOME: The percentage of metaphase II oocytes in HMG and rhFSH groups. STATISTICAL ANALYSIS: Statistical analyses were carried out by the Mann-Whitney, Fisher's exact, chi2 tests and Student's t-test.
RESULTS: No significant differences were found between two groups in regard to the demographic data, the ovarian response and pregnancy/implantation rates (P>0.05). The percentage of metaphase II oocytes in HMG and rhFSH groups were 81.3% versus 80.6%, respectively.
CONCLUSIONS: There were no significant differences between parameters such as, oocyte quality and percentage of metaphase II oocytes between these two groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925050     DOI: 10.1016/j.ejogrb.2004.11.007

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

Review 1.  Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis.

Authors:  Philippe Lehert; Joan C Schertz; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2010-09-16       Impact factor: 5.211

2.  GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology.

Authors:  Ana Marcia M Cota; Joao Batista A Oliveira; Claudia G Petersen; Ana L Mauri; Fabiana C Massaro; Liliane F I Silva; Andreia Nicoletti; Mario Cavagna; Ricardo L R Baruffi; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-04-27       Impact factor: 5.211

3.  Comparing a biosimilar follitropin alfa (Cinnal-fⓇ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT.

Authors:  Batool Hossein Rashidi; Khashayar Sayyari; Ramin Heshmat; Saeid Amanpour; Ensieh Shahrokh Tehraninejad; Masoumeh Masoumi; Farhang Rezaei
Journal:  Int J Reprod Biomed       Date:  2021-12-13

Review 4.  Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation.

Authors:  P E Levi Setti; C Alviggi; G L Colombo; C Pisanelli; C Ripellino; S Longobardi; P L Canonico; G De Placido
Journal:  J Endocrinol Invest       Date:  2014-12-06       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.